Bio-Techne Corporation

NASDAQ: TECH · Real-Time Price · USD
53.29
-0.31 (-0.58%)
At close: Aug 18, 2025, 3:59 PM
53.29
0.00%
After-hours: Aug 18, 2025, 05:31 PM EDT

Bio-Techne Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
1.16B 1.14B 1.11B 931.03M
Cost of Revenue
389.33M 366.89M 349.1M 298.18M
Gross Profit
769.73M 769.82M 756.5M 632.85M
Operating Income
206.69M 298.94M 296.59M 149.55M
Interest Income
3.32M 3.41M 794K 473K
Pretax Income
185.69M 338.66M 301.39M 148.18M
Net Income
168.1M 285.26M 272.05M 140.41M
Selling & General & Admin
396.83M 378.38M 372.77M 324.95M
Research & Development
96.66M 92.49M 87.14M 70.6M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
563.04M 470.87M 459.91M 395.55M
Interest Expense
15.74M 11.21M 11.31M 13.95M
Selling & Marketing Expenses
n/a 25.94M 33.77M 35.03M
Cost & Expenses
952.37M 837.76M 809.01M 693.74M
Income Tax Expense
17.58M 53.22M 38.29M 8.59M
Shares Outstanding (Basic)
157.71M 157.18M 156.88M 154.99M
Shares Outstanding (Diluted)
160.77M 161.85M 164.12M 161.93M
EPS (Basic)
1.07 1.81 1.73 0.91
EPS (Diluted)
1.05 1.76 1.66 0.87
EBITDA
310.37M 460.56M 420.12M 258.47M
EBIT
201.43M 349.87M 312.69M 162.13M
Depreciation & Amortization
111.71M 107.24M 101.07M 87.75M